Interestingly, while TRIM24 was initially identified as a transcriptional co-regulator, it has been recently shown to ubiquitinate TP53 for degradation in breast cancer (49) and could play a similar role in melanoma. This evidence concerns the gene TP53 and breast carcinoma.